China Regenerative Medicine International Limited
HKEX:8158.HK
0.11 (HKD) • At close September 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 69.487 | 231.612 | 282.897 | 185.339 | 47.971 | 72.952 | 755.52 | 356.987 | 27.751 | 2.817 | 0.51 | 1.377 | 0.128 | 2.621 | 0.03 | 24.448 | 88.76 | 64.952 | 42.427 | 20.571 |
| Cost of Revenue
| 50.064 | 193.989 | 215.17 | 140.328 | 19.052 | 45.946 | 580.218 | 219.462 | 9.41 | 1.431 | 0.352 | 1.615 | 0.085 | 0.933 | 0.024 | 17.165 | 65.543 | 50.492 | 28.77 | 14.649 |
| Gross Profit
| 19.423 | 37.623 | 67.727 | 45.011 | 28.919 | 27.006 | 175.302 | 137.525 | 18.341 | 1.386 | 0.158 | -0.238 | 0.043 | 1.688 | 0.006 | 7.283 | 23.217 | 14.46 | 13.657 | 5.922 |
| Gross Profit Ratio
| 0.28 | 0.162 | 0.239 | 0.243 | 0.603 | 0.37 | 0.232 | 0.385 | 0.661 | 0.492 | 0.31 | -0.173 | 0.336 | 0.644 | 0.2 | 0.298 | 0.262 | 0.223 | 0.322 | 0.288 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0.368 | 16.331 | 32.443 | 40.079 | 0 | 58.655 | 31.09 | 35.322 | 21.481 | 14.668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 38.891 | 22.213 | 43.054 | 158.74 | 201.055 | 324.017 | 358.476 | 322.464 | 303.249 | 171.125 | 136.879 | 74.23 | 69.685 | 54.528 | 50.976 | 52.933 | 0 | 20.9 | 13.881 | 10.107 |
| Selling & Marketing Expenses
| 6.644 | 3.604 | 4.392 | 26.64 | 56.264 | 134.695 | 133.905 | 66.796 | 33.078 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 128.544 | 25.817 | 47.446 | 185.38 | 257.319 | 458.712 | 404.189 | 389.26 | 303.249 | 171.125 | 136.879 | 74.23 | 69.685 | 54.528 | 50.976 | 52.933 | 0 | 20.9 | 13.881 | 10.107 |
| Other Expenses
| 2.343 | 6.791 | -41.44 | -4.373 | -7.193 | -22.27 | 0 | 20.894 | 9.13 | 2.101 | 5.662 | 6.788 | -2.07 | -2.911 | -0.94 | -16.2 | 37.387 | -1.273 | 0 | 0.216 |
| Operating Expenses
| 128.544 | 32.608 | 6.006 | 181.007 | 250.126 | 445.882 | 444.267 | 377.938 | 302.481 | 171.125 | 136.879 | 74.23 | 67.615 | 51.617 | 50.036 | 36.733 | 37.387 | 19.627 | 13.881 | 10.323 |
| Operating Income
| -109.121 | 8.62 | 64.586 | -128.143 | -224.139 | -636.412 | -268.965 | -199.391 | -165.448 | -228.038 | -272.716 | -67.68 | -67.572 | -49.929 | -29.565 | 17.901 | -14.17 | -5.167 | -0.224 | -4.401 |
| Operating Income Ratio
| -1.57 | 0.037 | 0.228 | -0.691 | -4.672 | -8.724 | -0.356 | -0.559 | -5.962 | -80.951 | -534.737 | -49.15 | -527.906 | -19.05 | -985.5 | 0.732 | -0.16 | -0.08 | -0.005 | -0.214 |
| Total Other Income Expenses Net
| 1.422 | -0.353 | -0.294 | -149.185 | -232.505 | -716.387 | 11.226 | -11.529 | -25.75 | -44.49 | -2.532 | -1.694 | -1.54 | -2.592 | -51.712 | -6.743 | 10.93 | 4.307 | 2.001 | 0.912 |
| Income Before Tax
| -107.699 | 8.267 | 64.292 | -277.328 | -456.644 | -1,352.799 | -257.739 | -210.92 | -191.198 | -272.528 | -275.248 | -69.374 | -69.112 | -52.521 | -81.277 | 11.158 | -3.24 | -0.86 | 1.777 | -3.489 |
| Income Before Tax Ratio
| -1.55 | 0.036 | 0.227 | -1.496 | -9.519 | -18.544 | -0.341 | -0.591 | -6.89 | -96.744 | -539.702 | -50.381 | -539.938 | -20.039 | -2,709.233 | 0.456 | -0.037 | -0.013 | 0.042 | -0.17 |
| Income Tax Expense
| 11.149 | 3.712 | 12.465 | 12.38 | -8.901 | -68.884 | -8.415 | -11.728 | 3.326 | -17.136 | -3.951 | -1.89 | -0.97 | -1.95 | -3.958 | 1.065 | 0.217 | -0.486 | -2.001 | -0.912 |
| Net Income
| -107.699 | 4.555 | 51.827 | -289.708 | -447.743 | -1,193.501 | -237.738 | -184.502 | -190.902 | -250.098 | -263.442 | -61.32 | -57.109 | -42.061 | -64.569 | 21.092 | -3.457 | -0.374 | 1.777 | -3.489 |
| Net Income Ratio
| -1.55 | 0.02 | 0.183 | -1.563 | -9.334 | -16.36 | -0.315 | -0.517 | -6.879 | -88.782 | -516.553 | -44.532 | -446.164 | -16.048 | -2,152.3 | 0.863 | -0.039 | -0.006 | 0.042 | -0.17 |
| EPS
| -0.38 | 0.016 | 0.18 | -1.8 | -5.09 | -1.36 | -2.7 | -0.21 | -0.22 | -0.4 | -0.53 | -0.17 | -0.16 | -0.13 | -0.38 | 0.19 | -0.037 | -0.005 | 0.027 | -0.051 |
| EPS Diluted
| -0.38 | 0.016 | 0.18 | -1.8 | -5.09 | -1.36 | -2.7 | -0.21 | -0.22 | -0.4 | -0.53 | -0.17 | -0.16 | -0.13 | -0.19 | 0.12 | -0.033 | -0.005 | 0.027 | -0.051 |
| EBITDA
| -97.804 | 8.791 | 64.664 | -126.412 | -172.448 | -566.71 | -207.582 | -144.111 | -113.556 | -179.062 | -242.252 | -49.04 | -49.85 | -32.901 | -11.08 | 27.371 | -12.494 | -4.522 | 0.422 | -3.764 |
| EBITDA Ratio
| -1.408 | 0.038 | 0.229 | -0.682 | -3.595 | -7.768 | -0.275 | -0.404 | -4.092 | -63.565 | -475.004 | -35.614 | -389.453 | -12.553 | -369.333 | 1.12 | -0.141 | -0.07 | 0.01 | -0.183 |